Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1989 Nov;28(5):535–544. doi: 10.1111/j.1365-2125.1989.tb03539.x

Garlic, onions and cardiovascular risk factors. A review of the evidence from human experiments with emphasis on commercially available preparations.

J Kleijnen 1, P Knipschild 1, G ter Riet 1
PMCID: PMC1380013  PMID: 2686739

Abstract

1. Claims for beneficial effects on cholesterol levels, fibrinolytic activity, and platelet aggregation are attributed both to fresh garlic and onions (or their extracts) and to commercially available preparations. 2. Regarding fresh garlic, the claims have been confirmed, but so far only at very high dosages. 3. For onions and commercially available supplements contradictory results have been reported. 4. All published trials showed severe methodological shortcomings. Some trials were not randomized and/or not blinded whilst this was possible, and in only one of every three studies more than 25 patients participated in each treatment group. In no trial was prognostic comparability of the treatment and the control groups ascertained. At the moment there is inadequate scientific justification for garlic supplementation.

Full text

PDF
541

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agarwal R. K., Dewar H. A., Newell D. J., Das B. Controlled trial of the effect of cycloalliin on the fibrinolytic activity of venous blood. Atherosclerosis. 1977 Jul;27(3):347–351. doi: 10.1016/0021-9150(77)90044-2. [DOI] [PubMed] [Google Scholar]
  2. Amonkar S. V., Reeves E. L. Mosquito control with active principle of garlic, Allium sativum. J Econ Entomol. 1970 Aug;63(4):1172–1175. doi: 10.1093/jee/63.4.1172. [DOI] [PubMed] [Google Scholar]
  3. Apitz-Castro R., Cabrera S., Cruz M. R., Ledezma E., Jain M. K. Effects of garlic extract and of three pure components isolated from it on human platelet aggregation, arachidonate metabolism, release reaction and platelet ultrastructure. Thromb Res. 1983 Oct 15;32(2):155–169. doi: 10.1016/0049-3848(83)90027-0. [DOI] [PubMed] [Google Scholar]
  4. Apitz-Castro R., Escalante J., Vargas R., Jain M. K. Ajoene, the antiplatelet principle of garlic, synergistically potentiates the antiaggregatory action of prostacyclin, forskolin, indomethacin and dypiridamole on human platelets. Thromb Res. 1986 May 1;42(3):303–311. doi: 10.1016/0049-3848(86)90259-8. [DOI] [PubMed] [Google Scholar]
  5. Ariga T., Oshiba S., Tamada T. Platelet aggregation inhibitor in garlic. Lancet. 1981 Jan 17;1(8212):150–151. doi: 10.1016/s0140-6736(81)90729-7. [DOI] [PubMed] [Google Scholar]
  6. Arora R. C., Arora S. Comparative effect of clofibrate, garlic and onion on alimentary hyperlipemia. Atherosclerosis. 1981 Jul;39(4):447–452. doi: 10.1016/0021-9150(81)90002-2. [DOI] [PubMed] [Google Scholar]
  7. Augusti K. T., Benaim M. E. Effect of essential oil of onion (allyl propyl disulphide) on blood glucose, free fatty acid and insulin levels of normal subjects. Clin Chim Acta. 1975 Apr 2;60(1):121–123. doi: 10.1016/0009-8981(75)90190-4. [DOI] [PubMed] [Google Scholar]
  8. Bayer T., Wagner H., Wray V., Dorsch W. Inhibitors of cyclo-oxygenase and lipoxygenase in onions. Lancet. 1988 Oct 15;2(8616):906–906. doi: 10.1016/s0140-6736(88)92503-2. [DOI] [PubMed] [Google Scholar]
  9. Bhushan S., Sharma S. P., Singh S. P., Agrawal S., Indrayan A., Seth P. Effect of garlic on normal blood cholesterol level. Indian J Physiol Pharmacol. 1979 Jul-Sep;23(3):211–214. [PubMed] [Google Scholar]
  10. Block E. The chemistry of garlic and onions. Sci Am. 1985 Mar;252(3):114–119. doi: 10.1038/scientificamerican0385-114. [DOI] [PubMed] [Google Scholar]
  11. Bordia A. K., Joshi H. K., Sanadhya Y. K., Bhu N. Effect of essential oil of garlic on serum fibrinolytic activity in patients with coronary artery disease. Atherosclerosis. 1977 Oct;28(2):155–159. doi: 10.1016/0021-9150(77)90152-6. [DOI] [PubMed] [Google Scholar]
  12. Bordia A., Bansal H. C., Arora S. K., Singh S. V. Effect of the essential oils of garlic and onion on alimentary hyperlipemia. Atherosclerosis. 1975 Jan-Feb;21(1):15–19. doi: 10.1016/0021-9150(75)90091-x. [DOI] [PubMed] [Google Scholar]
  13. Bordia A. Effect of garlic on blood lipids in patients with coronary heart disease. Am J Clin Nutr. 1981 Oct;34(10):2100–2103. doi: 10.1093/ajcn/34.10.2100. [DOI] [PubMed] [Google Scholar]
  14. Bordia A., Sharma K. D., Parmar Y. K., Verma S. K. Protective effect of garlic oil on the changes produced by 3 weeks of fatty diet on serum cholesterol, serum triglycerides, fibrinolytic activity and platelet adhesiveness in man. Indian Heart J. 1982 Mar-Apr;34(2):86–88. [PubMed] [Google Scholar]
  15. Chutani S. K., Bordia A. The effect of fried versus raw garlic on fibrinolytic activity in man. Atherosclerosis. 1981 Feb-Mar;38(3-4):417–421. doi: 10.1016/0021-9150(81)90058-7. [DOI] [PubMed] [Google Scholar]
  16. Ernst E. Cardiovascular effects of garlic (Allium sativum): a review. Pharmatherapeutica. 1987;5(2):83–89. [PubMed] [Google Scholar]
  17. Ernst E., Weihmayr T., Matrai A. Garlic and blood lipids. Br Med J (Clin Res Ed) 1985 Jul 13;291(6488):139–139. doi: 10.1136/bmj.291.6488.139-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Fenwick G. R., Hanley A. B. The genus Allium--Part 3. Crit Rev Food Sci Nutr. 1985;23(1):1–73. doi: 10.1080/10408398509527419. [DOI] [PubMed] [Google Scholar]
  19. Kamanna V. S., Chandrasekhara N. Hypocholesteremic activity of different fractions of garlic. Indian J Med Res. 1984 Apr;79:580–583. [PubMed] [Google Scholar]
  20. Kawakishi S., Morimitsu Y. New inhibitor of platelet aggregation in onion oil. Lancet. 1988 Aug 6;2(8606):330–330. doi: 10.1016/s0140-6736(88)92376-8. [DOI] [PubMed] [Google Scholar]
  21. Kendler B. S. Garlic (Allium sativum) and onion (Allium cepa): a review of their relationship to cardiovascular disease. Prev Med. 1987 Sep;16(5):670–685. doi: 10.1016/0091-7435(87)90050-8. [DOI] [PubMed] [Google Scholar]
  22. Luley C., Lehmann-Leo W., Möller B., Martin T., Schwartzkopff W. Lack of efficacy of dried garlic in patients with hyperlipoproteinemia. Arzneimittelforschung. 1986 Apr;36(4):766–768. [PubMed] [Google Scholar]
  23. Menon I. S., Kendal R. Y., Dewar H. A., Newell D. J. Effect of onions on blood fibrinolytic activity. Br Med J. 1968 Aug 10;3(5614):351–352. doi: 10.1136/bmj.3.5614.351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Qureshi A. A., Din Z. Z., Abuirmeileh N., Burger W. C., Ahmad Y., Elson C. E. Suppression of avian hepatic lipid metabolism by solvent extracts of garlic: impact on serum lipids. J Nutr. 1983 Sep;113(9):1746–1755. doi: 10.1093/jn/113.9.1746. [DOI] [PubMed] [Google Scholar]
  25. Sharma K. K., Gupta R. K., Gupta S., Samuel K. C. Antihyperglycemic effect of onion: effect on fasting blood sugar and induced hyperglycemia in man. Indian J Med Res. 1977 Mar;65(3):422–429. [PubMed] [Google Scholar]
  26. Sitprija S., Plengvidhya C., Kangkaya V., Bhuvapanich S., Tunkayoon M. Garlic and diabetes mellitus phase II clinical trial. J Med Assoc Thai. 1987 Mar;70 (Suppl 2):223–227. [PubMed] [Google Scholar]
  27. Slater N. G. . . . Or garlic. Lancet. 1979 Jun 16;1(8129):1294–1294. doi: 10.1016/s0140-6736(79)92252-9. [DOI] [PubMed] [Google Scholar]
  28. Ustünes L., Claeys M., Laekeman G., Herman A. G., Vlietinck A. J., Ozer A. Isolation and identification of two isomeric trihydroxy octadecenoic acids with prostaglandin E-like activity from onion bulbs (Allium cepa). Prostaglandins. 1985 May;29(5):847–865. doi: 10.1016/0090-6980(85)90142-x. [DOI] [PubMed] [Google Scholar]
  29. Yoshida S., Kasuga S., Hayashi N., Ushiroguchi T., Matsuura H., Nakagawa S. Antifungal activity of ajoene derived from garlic. Appl Environ Microbiol. 1987 Mar;53(3):615–617. doi: 10.1128/aem.53.3.615-617.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES